Los Angeles Capital Management LLC / NBIX
Los Angeles Capital Management LLC’s Neurocrine Biosciences Inc Position
Does Los Angeles Capital Management LLC own Neurocrine Biosciences Inc (NBIX)? Yes — 149.1K shares worth $20M (+0.08% of its 13F portfolio) as of Q1 2026, down from 1.29M shares the prior filed quarter.
Position Value
$20M
Q1 2026
Shares
149.1K
% of Portfolio
+0.08%
Quarters Held
27
currently held
Position History NBIX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 149.1K | $20M | +0.08% |
| Q4 2025 | 1.29M | $178M | +0.61% |
| Q3 2025 | 1.20M | $169M | +0.57% |
| Q2 2025 | 744.6K | $94M | +0.35% |
| Q1 2025 | 3.8K | $421,165 | 0.00% |
| Q4 2024 | 512.8K | $70M | +0.28% |
| Q3 2024 | 420.7K | $48M | +0.20% |
| Q2 2024 | 56.9K | $8M | +0.03% |
| Q1 2024 | 245.4K | $34M | +0.12% |
| Q4 2023 | 918.4K | $121M | +0.45% |
| Q3 2023 | 553.4K | $62M | +0.26% |
| Q2 2023 | 550.6K | $52M | +0.21% |
| Q1 2023 | 634.8K | $64M | +0.29% |
| Q4 2022 | 763.7K | $91M | +0.44% |
| Q3 2022 | 792.0K | $84M | +0.44% |
| Q3 2021 | 14.0K | $1M | +0.01% |
| Q2 2021 | 19.2K | $2M | +0.01% |
| Q1 2021 | 55.4K | $5M | +0.02% |
| Q4 2020 | 145.6K | $14M | +0.06% |
| Q3 2020 | 176.8K | $17M | +0.08% |
| Q2 2020 | 133.1K | $16M | +0.08% |
| Q1 2020 | 10.7K | $926,000 | +0.01% |
| Q4 2019 | 8.3K | $892,000 | 0.00% |
| Q3 2019 | 3.6K | $322,000 | 0.00% |
| Q2 2019 | 17.9K | $2M | +0.01% |
| Q1 2019 | 25.0K | $2M | +0.01% |
| Q4 2018 | 4.0K | $283,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of NBIX.